Mindfulness Meditation Intervention for Colorectal Cancer Patients and Caregivers
- Conditions
- Colorectal Cancer
- Interventions
- Behavioral: Audio-Based Mindfulness
- Registration Number
- NCT02423720
- Lead Sponsor
- University of California, San Francisco
- Brief Summary
This is a audio based mindfulness meditation intervention for colorectal cancer patients and caregivers. A 8-week single arm study will be conducted among University of California, San Francisco (UCSF) patients with metastatic colorectal cancer undergoing chemotherapy and caregivers of these patients (44 participants total).
- Detailed Description
A metastatic cancer diagnosis is associated with high levels of distress in both patients and caregivers. The investigators hypothesize that an audio-based mindfulness intervention will be an effective means to reduce distress and improve quality of life among patients with advanced cancer and their caregivers. With the Being Present study, conduct an 8-week single arm study among UCSF patients with metastatic colorectal cancer undergoing chemotherapy and caregivers of these patients (44 participants total). Participants will receive an informational booklet containing a practice log and a MP3 player containing an introductory lecture and guided meditations. Practice reminders will be sent via text messages. Emails will contain practice assignments and links to validated survey instruments. The survey instruments (National Comprehensive Cancer Network (NCCN) Distress Thermometer and National Institutes of Health (NIH) Patient Reported Outcomes Measurement Information System (PROMIS) adult short forms) will measure global health, anxiety, depression, fatigue, and sleep quality before, during, and after the intervention to obtain preliminary estimates of the efficacy of the intervention among patients and caregivers on self-reported outcomes. Qualitative data will be collected from pre- and post-intervention interviews.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 53
Eligible patients must:
- Carry a diagnosis of metastatic colon, rectum, or small bowel adenocarcinoma
- Anticipate receiving chemotherapy for at least 12 weeks total from the time of recruitment
- Have life expectancy of at least 6 months
- Have Karnofsky Performance Status ≥60
- Be able to speak and read English
- Have access to a mobile phone
- Be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet
- Have a distress level of ≥3 on the NCCN Distress Thermometer (DT).[1, 40]
- An effort will always be made to recruit patient and caregiver pairs, but unpaired patients are also eligible
Eligible caregivers are a spouse/partner, other family member, or a close friend of a patient with metastatic colon, rectum, or small bowel adenocarcinoma.
Eligible caregivers must:
- Be able to speak and read English
- Have access to a mobile phone
- Be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet
This study is limited the study to patients with metastatic colon, rectum, or small bowel adenocarcinoma, because treatment regimens and disease trajectories for these disease groups are similar.
Deafness, Current meditation practice (>2 episodes or >1 hour total, weekly), and current enrollment in a stress reduction program are exclusion criteria for the intervention study because the study is designed as an audio-based introduction to mindfulness meditation.
Patients with a DT level >7 will be considered on a case-by- case basis. Patients and caregivers who participate in a focus group and meet criteria for the intervention will be given the opportunity to participate: data will be collected, but these patients/participants will not be included in the final analyses so as not to bias the results.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Study Intervention Audio-Based Mindfulness Audio-based mindfulness intervention A 8-week single arm pilot study will be conducted among Helen Diller Famiily Comprehensive Cancer Center (HDFCCC) patients with metastatic colorectal cancer receiving chemotherapy and their caregivers (44 participants, total). Participants will receive an informational booklet containing a practice log and an MP3 player containing an introductory lecture and guided meditations. Practice reminders will be sent via text messages. Weekly emails will contain practice instructions and links to validated questionnaires.
- Primary Outcome Measures
Name Time Method Proportion of eligible patients and caregivers who agree to be screened, consent to participate, and complete or partially complete the intervention, as a measure of feasibility and acceptability. 8 weeks Adherence to the intervention, as assessed by frequency and duration of practicing the exercises (recorded in a log and responses to text messages) 8 weeks
- Secondary Outcome Measures
Name Time Method Reasons for non-participation/non-continuation of the intervention, as a measure of feasibility and acceptability 8 weeks Adherence to the intervention, as assessed by frequency and duration of practicing the exercises (recorded in a log and responses to text messages) 8 weeks Reasons for ineligibility, as a measure of feasibility 8 weeks Proportion of enrolled patients and caregivers who refuse to participate in or complete the intervention, as a measure of feasibility and acceptability 8 weeks
Trial Locations
- Locations (1)
University of California San Francisco
🇺🇸San Francisco, California, United States